You searched for
We found 9 articles
Leisure Time Activity and Nutrition Program (LEAN)
The purpose of this investigation is to conduct an 8-week pilot study to examine the effects of two different leisure-time…
01 Jan 2013
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
Parathyroid hormone (PTH) increases bone formation and thereby improves bone density and bone strength in postmenopausal women with osteoporosis. However,…
01 Jan 2013
Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: This…
01 Jan 2013
BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia
The purpose of this clinical research study is to understand the safety and efficacy of BMS-354825 in patients with chronic,…
01 Jan 2013
PRIDE – Prograf Investigation of Diet and Exercise. A Pilot Trial of the Effect of Dietary and Exercise Intervention in Patients Who Have Received a Renal Transplant on Tacrolimus (Prograf)
The purpose of this trial is to investigate whether a combined dietary and exercise intervention, added to standard care, reduces…
01 Jan 2013
The Rabeprazole and Esomeprazole Reflux Assessment Trial (TREAT)
The primary objective of this study is to compare, the number of patients with heartburn and regurgitation symptom resolution after…
01 Jan 2013
SMOOTH – Blood Pressure Control in Diabetic/Obese Patients
The primary objective of the SMOOTH study was to demonstrate that, when combined with hydrochlorothiazide (12.5 mg), telmisartan (80 mg)…
01 Jan 2013
Cognitive Behavioural Therapy for Obesity
The purpose of this study is to evaluate the effectiveness of a cognitive behavioural treatment (CBT) designed to help obese…
01 Jan 2013
A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
The purpose of this study is to compare the efficacy of visilizumab to placebo in subjects with intravenous steroid-refractory ulcerative…
01 Jan 2013
